AOTI INC (AOTI) — Half Year Results

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the AOTI Half Year Results Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged, and they can be submitted at any time using the Q and A tab situated on the right hand corner of your screen. Simply type in your questions and press send. Before we begin, I would like to submit the following poll. I would now like to hand you over to CEO, Mike Griffiths. Good afternoon. Yes. Good afternoon. Thank you for joining us here. So I'm Mike Rivers, and here's my CEO and our CFO here, Josh Pankanja, and we're gonna be walking you through our midyear presentation here. Morning, everyone. Morning. So we'll go to the thing now. Make you lunch. Okay. So we'll walk you through. So this really is a transformational growth year for the company. And to remind everybody, we have a unique multimodality therapy called TWO two, double wound oxygen, and we are already the leader in the double oxygen space. It's differentiated by not only its clinical utility, but also the fact it delivers longer, more durable healing of chronic wounds, which has significant cost and health economic benefits as well. We already are generating significant early revenues with strong profitable growth in the sectors that we're in, and the most transformational news for the company is the impending CMS, which is the Center for Medicare and Medicaid Services in The US, coverage for the therapy, which was announced as a provisional, local coverage determination in July of this year, which is now in a final process that will complete by July of next year. Our existing commercial infrastructure, we have been honing and and making adjustments to such that we can maximize our footprint and improve our best practices, ...